Filing Details
- Accession Number:
- 0001410939-22-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-01 19:03:34
- Reporting Period:
- 2022-03-30
- Accepted Time:
- 2022-04-01 19:03:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Iveric Bio Inc. | ISEE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277478 | Glenn Sblendorio | C/O Iveric Bio, Inc. 8 Sylvan Way Parsippany NJ 07054 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-30 | 1,213 | $2.94 | 280,902 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-30 | 1,213 | $17.00 | 279,689 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-31 | 1,400 | $2.94 | 281,089 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-31 | 1,400 | $17.02 | 279,689 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-01 | 40,756 | $2.94 | 320,445 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-01 | 40,756 | $17.50 | 279,689 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-30 | 1,213 | $0.00 | 1,213 | $2.94 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-31 | 1,400 | $0.00 | 1,400 | $2.94 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-04-01 | 40,756 | $0.00 | 40,756 | $2.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 367,156 | 2027-12-18 | No | 4 | M | Direct | |
| 365,756 | 2027-12-18 | No | 4 | M | Direct | |
| 325,000 | 2027-12-18 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021, and as described in the Registrant's Proxy Statement for its 2022 Annual Meeting of the Stockholders, as filed with the Securities and Exchange Commission on March 30, 2022.
- The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $17.00 to $17.01 per share on March 30, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $17.00 to $17.02 per share on March 31, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $17.00 to $17.83 per share on April 1, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
Billionaire Hedge Funds
